Selected research
Market Structure
Global Blister Pack Pharmaceutical Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Blister Pack Pharmaceutical Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Blister Pack Pharmaceutical Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Blister Pack Pharmaceutical Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Blister Pack Pharmaceutical Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Blister Pack Pharmaceutical Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Blister Pack Pharmaceutical Products include Sun Pharmaceutical Industries Ltd, Sanofi, Johnson & Johnson, Novartis AG, Merck, Pfizer Inc, GlaxoSmithKline plc, Roche Holding AG and Cadila Healthcare, etc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Blister Pack Pharmaceutical Products market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Blister Pack Pharmaceutical Products and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Blister Pack Pharmaceutical Products revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Blister Pack Pharmaceutical Products market size, projected growth trends, production technologies, key applications, and end-use industries.
Blister Pack Pharmaceutical Products Segment by Company
Sun Pharmaceutical Industries Ltd
Sanofi
Johnson & Johnson
Novartis AG
Merck
Pfizer Inc
GlaxoSmithKline plc
Roche Holding AG
Cadila Healthcare, etc.
Allergan
Blister Pack Pharmaceutical Products Segment by Type
Tablets
Capsules
Blister Pack Pharmaceutical Products Segment by Application
Veterinary Drugs
Pharmaceuticals
Nutraceuticals and Supplements
Blister Pack Pharmaceutical Products Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blister Pack Pharmaceutical Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Blister Pack Pharmaceutical Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blister Pack Pharmaceutical Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Blister Pack Pharmaceutical Products in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Blister Pack Pharmaceutical Products industry.
Chapter 3: Detailed analysis of Blister Pack Pharmaceutical Products companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Blister Pack Pharmaceutical Productsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablets
- Capsules
Applications
- Veterinary Drugs
- Pharmaceuticals
- Nutraceuticals and Supplements
Companies covered
- Sun Pharmaceutical Industries Ltd
- Sanofi
- Johnson & Johnson
- Novartis AG
- Merck
- Pfizer Inc
- GlaxoSmithKline plc
- Roche Holding AG
- Cadila Healthcare, etc.
- Allergan
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Blister Pack Pharmaceutical Products Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Tablets
- 1.2.3 Capsules
- 1.3 Market Analysis by Application
- 1.3.1 Global Blister Pack Pharmaceutical Products Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Veterinary Drugs
- 1.3.3 Pharmaceuticals
- 1.3.4 Nutraceuticals and Supplements
- 1.4 Global Market Growth Prospects
- 1.5 Global Blister Pack Pharmaceutical Products Growth Trends by Region
- 1.5.1 Global Blister Pack Pharmaceutical Products Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Blister Pack Pharmaceutical Products Market Size by Region (2021-2026)
- 1.5.3 Blister Pack Pharmaceutical Products Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Blister Pack Pharmaceutical Products Market Dynamics
- 2.1 Blister Pack Pharmaceutical Products Industry Trends
- 2.2 Blister Pack Pharmaceutical Products Industry Drivers
- 2.3 Blister Pack Pharmaceutical Products Industry Opportunities and Challenges
- 2.4 Blister Pack Pharmaceutical Products Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Blister Pack Pharmaceutical Products Revenue by Company (2021-2026)
- 3.2 Global Blister Pack Pharmaceutical Products Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Blister Pack Pharmaceutical Products Key Company Head office and Area Served
- 3.4 Global Blister Pack Pharmaceutical Products Company, Product Type & Application
- 3.5 Global Blister Pack Pharmaceutical Products Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Blister Pack Pharmaceutical Products Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Blister Pack Pharmaceutical Products Players Market Share by Revenue in 2025
- 3.6.3 2025 Blister Pack Pharmaceutical Products Tier 1, Tier 2, and Tier 3
4 Blister Pack Pharmaceutical Products Market by Type
- 4.1 Global Blister Pack Pharmaceutical Products Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Blister Pack Pharmaceutical Products Market Size by Type (2021-2032)
- 4.3 Global Blister Pack Pharmaceutical Products Market Size Share by Type (2021-2032)
5 Blister Pack Pharmaceutical Products Market by Application
- 5.1 Global Blister Pack Pharmaceutical Products Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Blister Pack Pharmaceutical Products Market Size by Application (2021-2032)
- 5.3 Global Blister Pack Pharmaceutical Products Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Sun Pharmaceutical Industries Ltd
- 6.1.1 Sun Pharmaceutical Industries Ltd Company Information
- 6.1.2 Sun Pharmaceutical Industries Ltd Business Overview
- 6.1.3 Sun Pharmaceutical Industries Ltd Blister Pack Pharmaceutical Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Sun Pharmaceutical Industries Ltd Blister Pack Pharmaceutical Products Product Portfolio
- 6.1.5 Sun Pharmaceutical Industries Ltd Recent Developments
- 6.2 Sanofi
- 6.2.1 Sanofi Company Information
- 6.2.2 Sanofi Business Overview
- 6.2.3 Sanofi Blister Pack Pharmaceutical Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Sanofi Blister Pack Pharmaceutical Products Product Portfolio
- 6.2.5 Sanofi Recent Developments
- 6.3 Johnson & Johnson
- 6.3.1 Johnson & Johnson Company Information
- 6.3.2 Johnson & Johnson Business Overview
- 6.3.3 Johnson & Johnson Blister Pack Pharmaceutical Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Johnson & Johnson Blister Pack Pharmaceutical Products Product Portfolio
- 6.3.5 Johnson & Johnson Recent Developments
- 6.4 Novartis AG
- 6.4.1 Novartis AG Company Information
- 6.4.2 Novartis AG Business Overview
- 6.4.3 Novartis AG Blister Pack Pharmaceutical Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Novartis AG Blister Pack Pharmaceutical Products Product Portfolio
- 6.4.5 Novartis AG Recent Developments
- 6.5 Merck
- 6.5.1 Merck Company Information
- 6.5.2 Merck Business Overview
- 6.5.3 Merck Blister Pack Pharmaceutical Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Merck Blister Pack Pharmaceutical Products Product Portfolio
- 6.5.5 Merck Recent Developments
- 6.6 Pfizer Inc
- 6.6.1 Pfizer Inc Company Information
- 6.6.2 Pfizer Inc Business Overview
- 6.6.3 Pfizer Inc Blister Pack Pharmaceutical Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Pfizer Inc Blister Pack Pharmaceutical Products Product Portfolio
- 6.6.5 Pfizer Inc Recent Developments
- 6.7 GlaxoSmithKline plc
- 6.7.1 GlaxoSmithKline plc Company Information
- 6.7.2 GlaxoSmithKline plc Business Overview
- 6.7.3 GlaxoSmithKline plc Blister Pack Pharmaceutical Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 GlaxoSmithKline plc Blister Pack Pharmaceutical Products Product Portfolio
- 6.7.5 GlaxoSmithKline plc Recent Developments
- 6.8 Roche Holding AG
- 6.8.1 Roche Holding AG Company Information
- 6.8.2 Roche Holding AG Business Overview
- 6.8.3 Roche Holding AG Blister Pack Pharmaceutical Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Roche Holding AG Blister Pack Pharmaceutical Products Product Portfolio
- 6.8.5 Roche Holding AG Recent Developments
- 6.9 Cadila Healthcare, etc.
- 6.9.1 Cadila Healthcare, etc. Company Information
- 6.9.2 Cadila Healthcare, etc. Business Overview
- 6.9.3 Cadila Healthcare, etc. Blister Pack Pharmaceutical Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Cadila Healthcare, etc. Blister Pack Pharmaceutical Products Product Portfolio
- 6.9.5 Cadila Healthcare, etc. Recent Developments
- 6.10 Allergan
- 6.10.1 Allergan Company Information
- 6.10.2 Allergan Business Overview
- 6.10.3 Allergan Blister Pack Pharmaceutical Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Allergan Blister Pack Pharmaceutical Products Product Portfolio
- 6.10.5 Allergan Recent Developments
7 North America
- 7.1 North America Blister Pack Pharmaceutical Products Market Size (2021-2032)
- 7.2 North America Blister Pack Pharmaceutical Products Market Size by Type
- 7.2.1 North America Blister Pack Pharmaceutical Products Market Size by Type (2021-2026)
- 7.2.2 North America Blister Pack Pharmaceutical Products Market Size by Type (2027-2032)
- 7.2.3 North America Blister Pack Pharmaceutical Products Market Share by Type (2021-2032)
- 7.3 North America Blister Pack Pharmaceutical Products Market Size by Application
- 7.3.1 North America Blister Pack Pharmaceutical Products Market Size by Application (2021-2026)
- 7.3.2 North America Blister Pack Pharmaceutical Products Market Size by Application (2027-2032)
- 7.3.3 North America Blister Pack Pharmaceutical Products Market Share by Application (2021-2032)
- 7.4 North America Blister Pack Pharmaceutical Products Market Size by Country
- 7.4.1 North America Blister Pack Pharmaceutical Products Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Blister Pack Pharmaceutical Products Market Size by Country (2021-2026)
- 7.4.3 North America Blister Pack Pharmaceutical Products Market Size by Country (2027-2032)
- 7.4.4 North America Blister Pack Pharmaceutical Products Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Blister Pack Pharmaceutical Products Market Size (2021-2032)
- 8.2 Europe Blister Pack Pharmaceutical Products Market Size by Type
- 8.2.1 Europe Blister Pack Pharmaceutical Products Market Size by Type (2021-2026)
- 8.2.2 Europe Blister Pack Pharmaceutical Products Market Size by Type (2027-2032)
- 8.2.3 Europe Blister Pack Pharmaceutical Products Market Share by Type (2021-2032)
- 8.3 Europe Blister Pack Pharmaceutical Products Market Size by Application
- 8.3.1 Europe Blister Pack Pharmaceutical Products Market Size by Application (2021-2026)
- 8.3.2 Europe Blister Pack Pharmaceutical Products Market Size by Application (2027-2032)
- 8.3.3 Europe Blister Pack Pharmaceutical Products Market Share by Application (2021-2032)
- 8.4 Europe Blister Pack Pharmaceutical Products Market Size by Country
- 8.4.1 Europe Blister Pack Pharmaceutical Products Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Blister Pack Pharmaceutical Products Market Size by Country (2021-2026)
- 8.4.3 Europe Blister Pack Pharmaceutical Products Market Size by Country (2027-2032)
- 8.4.4 Europe Blister Pack Pharmaceutical Products Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Blister Pack Pharmaceutical Products Market Size (2021-2032)
- 9.2 China Blister Pack Pharmaceutical Products Market Size by Type
- 9.2.1 China Blister Pack Pharmaceutical Products Market Size by Type (2021-2026)
- 9.2.2 China Blister Pack Pharmaceutical Products Market Size by Type (2027-2032)
- 9.2.3 China Blister Pack Pharmaceutical Products Market Share by Type (2021-2032)
- 9.3 China Blister Pack Pharmaceutical Products Market Size by Application
- 9.3.1 China Blister Pack Pharmaceutical Products Market Size by Application (2021-2026)
- 9.3.2 China Blister Pack Pharmaceutical Products Market Size by Application (2027-2032)
- 9.3.3 China Blister Pack Pharmaceutical Products Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Blister Pack Pharmaceutical Products Market Size (2021-2032)
- 10.2 Asia Blister Pack Pharmaceutical Products Market Size by Type
- 10.2.1 Asia Blister Pack Pharmaceutical Products Market Size by Type (2021-2026)
- 10.2.2 Asia Blister Pack Pharmaceutical Products Market Size by Type (2027-2032)
- 10.2.3 Asia Blister Pack Pharmaceutical Products Market Share by Type (2021-2032)
- 10.3 Asia Blister Pack Pharmaceutical Products Market Size by Application
- 10.3.1 Asia Blister Pack Pharmaceutical Products Market Size by Application (2021-2026)
- 10.3.2 Asia Blister Pack Pharmaceutical Products Market Size by Application (2027-2032)
- 10.3.3 Asia Blister Pack Pharmaceutical Products Market Share by Application (2021-2032)
- 10.4 Asia Blister Pack Pharmaceutical Products Market Size by Country
- 10.4.1 Asia Blister Pack Pharmaceutical Products Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Blister Pack Pharmaceutical Products Market Size by Country (2021-2026)
- 10.4.3 Asia Blister Pack Pharmaceutical Products Market Size by Country (2027-2032)
- 10.4.4 Asia Blister Pack Pharmaceutical Products Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Blister Pack Pharmaceutical Products Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Blister Pack Pharmaceutical Products Market Size by Type
- 11.2.1 South America, Middle East & Africa Blister Pack Pharmaceutical Products Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Blister Pack Pharmaceutical Products Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Blister Pack Pharmaceutical Products Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Blister Pack Pharmaceutical Products Market Size by Application
- 11.3.1 South America, Middle East & Africa Blister Pack Pharmaceutical Products Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Blister Pack Pharmaceutical Products Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Blister Pack Pharmaceutical Products Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Blister Pack Pharmaceutical Products Market Size by Country
- 11.4.1 South America, Middle East & Africa Blister Pack Pharmaceutical Products Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Blister Pack Pharmaceutical Products Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Blister Pack Pharmaceutical Products Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Blister Pack Pharmaceutical Products Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst